Prepn process and formula of compound chondroitin sulfate tablet

A technology of chondroitin sulfate and cartilage sulfate, applied in bone diseases, drug combination, pill delivery, etc.

Inactive Publication Date: 2008-01-02
唐山市福乐药业有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no literature report at present, which can combine the above two aspects of research results to develop an effective drug or health food with health care and auxiliary treatment functions.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0012] The present invention is described in detail below in conjunction with embodiment. According to the composition of raw materials of composite chondroitin sulfate bone strengthening tablet of the present invention, three specific embodiments given in the following table can be arranged.

[0013] raw material

name

Example 1

Example 2

Example 3

weight%

Weight g

weight%

Weight g

weight%

Weight g

Sulfate cartilage

white

30

900

40

1200

50

1500

Glucosamine

sugar hydrochloride

60

1800

50

1500

40

1200

Soy isoyellow

ketone

2

60

2.5

75

3

90

Auxiliary

material

Microcrystalline

fiber

white

5

150

5

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to health food with the function of preventing and auxiliarily treating osteoarthropathy, and is especially preparation process and formula of compound chondroitin sulfate tablet. The compound chondroitin sulfate tablet formula contains chodroitin sulfate 30-50 wt%, glycosamine chlorate 40-60 wt%, soybean isoflvone 2-3 wt%except supplementary material. The compound chondroitin sulfate tablet has both the treating function of chondroitin sulfate and the preventing function of soybean isoflvone, and is one kind of good health food with fast disintegrating, high leaching rate, easy taking and high absorption and other features.

Description

Technical field: [0001] The invention relates to a health food for the prevention and auxiliary treatment of osteoarthritis, in particular to a composite chondroitin sulfate bone-building tablet. Background technique: [0002] Rheumatoid arthritis, osteoarthritis, and osteoporosis have become common diseases among middle-aged and elderly people. Among people over 40 years old, the incidence rate of such diseases is as high as 74%. At present, common drugs for treating such diseases include analgesics, non-steroidal anti-inflammatory drugs, local hormone injections, and intra-articular injections of hyaluronidase, etc. These drugs generally only relieve symptoms, and are difficult to completely improve joint function and condition. Although many studies have shown that the combination of chondroitin sulfate and glucosamine hydrochloride is aimed at the application of osteoarthritis, the improvement rate of its clinical symptoms can reach 50-80%, and the good effect can last f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/726A61K9/20A61P19/02A61P19/10
Inventor 周立新
Owner 唐山市福乐药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products